v3.26.1
Investment in Associate (Tables)
12 Months Ended
Dec. 31, 2025
Investment in Associate [Abstract]  
Schedule of Investment in Neuronomics as an Associate

A continuity of the investment in Neuronomics as an associate is as follows:

 

Balance as at December 31, 2024  $
-
 
Investment in associate   2,499,440 
Share of loss for the year   (75,506)
Balance as at December 31, 2025  $2,423,934 
Schedule of Financial Information for Neuronomics

Summarized financial information for Neuronomics as at December 31, 2025 and for the year ended December 31, 2025 is as follows:

 

   December 31,
2025
 
Current and total assets  $514,391 
Current and total liabilities   (111,333)
Total shareholders’ equity   (403,058)

 

   Year ended December 31,
2025
 
Revenue  $514,020 
Operating expenses   (843,777)
Net loss   (329,757)